GlassScriptPhysician profile
Abusayeed M Feroz
NPI 1093872392
$14,764.15
in general payments reported to CMS, 2019-2025
16 companies · $1,797 in 2025
The $1,797 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $767 · 2020: $211 · 2021: $54.93 · 2022: $97.31 · 2023: $10K · 2024: $1,631 · 2025: $1,797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $12K · Travel and Lodging: $901 · Food and Beverage: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $12,000.00 |
| Travel and Lodging | $901.24 |
| Food and Beverage | $733.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,294.88 | 2023-2025 | Da Vinci Surgical System, Ion |
| Glaxosmithkline, LLC. | $353.85 | 2019-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $338.16 | 2019-2024 | Fasenra, Andexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $137.70 | 2019 | |
| Allergan, INC. | $102.11 | 2020 | |
| Abbvie INC. | $97.31 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $90.53 | 2019 | |
| Mylan Specialty L.P. | $83.10 | 2019-2020 | |
| Advanced Respiratory, INC | $65.05 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $51.43 | 2019 | |
| Pfizer INC. | $44.63 | 2019-2021 | |
| United Therapeutics Corporation | $24.67 | 2020 | |
| Grifols USA, LLC | $24.59 | 2019 | |
| Potrero Medical, INC. | $20.16 | 2025 | |
| Sunovion Pharmaceuticals INC. | $18.00 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $17.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abusayeed Feroz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.